MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis.
OMNIlife science received FDA 510(k) clearance to market Active Spacer, a robotic tissue balancing device for use with OMNIBotics® robotic-assisted total knee replacement technology.
NuVasive received FDA 510(k) clearance for use of redesigned MAGEC® growing rods with the RELINE® Small Stature pediatric deformity fixation system.